fashion -WSS

fashion

author：fashion 2025-08-23 08:57:12 - browse：928

Who polices algorithms? How would you name the first approved CRISPR medicine? And what pairs well with a biotech downturn?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability. Then, biotech veteran Michael Gilman calls in to offer a behind-the-scenes peek at what it’s like to be a startup CEO in this economic downturn — and which cocktail recipes help make it bearable. We also discuss a pioneering approval for a genome-editing medicine.

For more on what we cover, here’s the UnitedHealth story; here’s more on the CRISPR approval; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Biden warns of ‘dark winter’ during final presidental debate

WSS

A new crop of companies is reshaping the health data economy

Former reverend arrested for allegedly killing 8

UHS says company favors patients whose insurance pays more

Surgery pushed Ben Carson to fame

Cano Health’s bankruptcy is a warning for Medicare Advantage

The Biogen Aduhelm mess could happen again

entertainment

fashion

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Duchenne breakthrough therapy leaves behind pioneering families

New lawsuit accuses health insurer Cigna of denying claims in bulk

Bright Health sells Medicare Advantage business to Molina

A new crop of companies is reshaping the health data economy

BioMarin wins approval for gene therapy to treat hemophilia A

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

What causes rare myocarditis in young men after Covid vaccines?

explore

Top private equity targets in 2023: cardiology, clinical trials, lasers

How doctors’ personal politics affect patients

Rise in cancer among younger people worries and puzzles doctors

Gene therapy for Afghan refugees’ infant will be fully covered

STAT Report: Patient voices and perspectives

Device maker Teleflex to acquire urology company for $600M

knowledge

hotspot

hotspot

knowledge